Alivus Life Sciences Ltd Stock News

Alivus Life Sciences Ltd Share Price
Detail Overview
Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE
₹1,269.00
+11.10(+0.88%)
As on 22 Oct 2026 at 15:56
As of 22 Oct 2026 at 15:56, Alivus Life Sciences Ltd is trading at ₹1,269.00. The 52-week range stands at ₹819.00–₹1,493.80, with a market cap of ₹15.56 thousand crore. At a P/E of 25.03 and a dividend yield of 0.39%, it is a mid-cap stock in the Pharmaceuticals sector.

ALIVUS Price Chart

Market Cap
₹15.56K Cr
PE Ratio
25.03
ROCE
22.33%

Alivus Life Sciences Ltd Latest News

View More
22 OCT 2026 | Thursday
Alivus Life Sciences to review financial results at board meeting October 29, 2026
21 OCT 2026 | Wednesday
Alivus Life Sciences to review financial results at board meeting October 29, 2026
18 AUG 2026 | Tuesday
Alivus Life Sciences to acquire 76% stake in IQGEN-X Pharma for approximately Rs 9.12 crores
06 AUG 2026 | Thursday
Alivus Life Sciences recommends Rs 5.00 per share dividend at September 2026 meeting
30 JUL 2026 | Thursday
Alivus Life Sciences’ board approved allotment of shares to employees exercising stock options
30 JUL 2026 | Thursday
Alivus Life Sciences reports Rs 1,601 million net profit, revenue up 6.4% year-over-year
24 JUL 2026 | Friday
Alivus Life Sciences to table results
24 JUL 2026 | Friday
Alivus Life Sciences to discuss results
18 MAY 2026 | Monday
Alivus Life Sciences rises after Q4 PAT climbs 15% YoY to Rs 163 cr
16 MAY 2026 | Saturday
Alivus Life Sciences Q4 PAT climbs 15% YoY to Rs 163 cr

Not sure where to start?

Book a free 30-minute consultation with our investment experts today!

Invest Now